Inhibitory effect of sesaminol glucosides on lipopolysaccharide-induced NF-κB activation and target gene expression in cultured rat astrocytes

Neuroscience Research

Volumn 56, Issue 2, 2006, Pages 204-212

  Lee, Sun Young ^a   Son, Dong Ju ^a   Lee, Yong Kyoung ^a   Lee, Jae Woong ^a   Lee, Hwa Jung ^a   Yun, Young Won ^a   Ha, Tae Youl ^b   Hong, Jin Tae ^a  

^a Chungbuk National University   (South Korea)

^b Korea Food Research Institute   (South Korea)

Author keywords

Alzheimer's disease; Astrocytes; Inflammatory reaction; Lipopolysaccharide; NF B; Sesaminol glucosides

Indexed keywords

ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 2; CYTOPLASM PROTEIN; GLUTATHIONE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIGNAN DERIVATIVE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PHOSPHOLIPASE A2; PROTEIN INHIBITOR; PROTEIN P50; REACTIVE OXYGEN METABOLITE; SESAMINOL GLUCOSIDE; UNCLASSIFIED DRUG;

AEROBIC METABOLISM; ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; ASTROCYTE; CELL CULTURE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DNA BINDING; DOSE RESPONSE; DRUG MECHANISM; GENE EXPRESSION; GENE EXPRESSION REGULATION; INFLAMMATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; TRANSCRIPTION REGULATION;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; ASTROCYTES; BLOTTING, WESTERN; BRAIN; CELL SURVIVAL; CELLS, CULTURED; DIOXOLES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME ACTIVATION; FURANS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCOSIDES; IMMUNOHISTOCHEMISTRY; LIPOPOLYSACCHARIDES; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; RATS;

EID: 33748753175     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2006.06.005     Document Type: Article

References (52)

1. Acarin L., Peluffo H., Gonzalez B., and Castellano B. Expression of inducible nitric oxide synthase and cyclooxygenase-2 after excitotoxic damage to the immature rat brain. J. Neurosci. Res. 68 (2002) 745-754
2. Allan S.M., and Rothwell N.J. Inflammation in central nervous system injury. Phil. Trans. R. Soc. Lond. B: Biol. Sci. 358 (2003) 1669-1677
3. Ashe K.H. Learning and memory in transgenic mice modeling Alzheimer's disease. Learn. Mem. 8 (2001) 301-308
4. Ayasolla K., Khan M., Si Jeng K.C., Hou R.C., Wang J.C., and Ping L.I. Sesamin inhibits lipopolysaccharide-induced cytokine production by suppression of p38 mitogen-activated protein kinase and nuclear factor-kappaB. Immunol. Lett. 97 (2005) 101-106
5. Boissiere F., Hunot S., Faucheux B., Duyckaerts C., Hauw J.J., Agid Y., and Hirsch E.C. Nuclear translocation of NF-kappaB in cholinergic neurons of patients with Alzheimer's disease. Neuroreport 8 (1997) 2849-2852
6. Cacquevel M., Lebeurrier N., Cheenne S., and Vivien D. Cytokines in neuroinflammation and Alzheimer's disease. Curr. Drug Targets 5 (2004) 529-534
7. Carracedo A., Geelen M.J., Diez M., Hanada K., Guzman M., and Velasco G. Ceramide sensitizes astrocytes to oxidative stress: protective role of cannabinoids. Biochem. J. 380 (2004) 435-440
8. Castro-Alcaraz S., Miskolci V., Kalasapudi B., Davidson D., and Vancurova I. NF-kappa B regulation in human neutrophils by nuclear I kappa B alpha: correlation to apoptosis. J. Immunol. 169 (2002) 3947-3953
9. Cotrina M.L., and Nedergaard M. Astrocytes in the aging brain. J. Neurosci. Res. 67 (2002) 1-10
10. Fiebich B.L., Hofer T.J., Lieb K., Huell M., Butcher R.D., Schumann G., Schulze-Osthoff K., and Bauer J. The non-steroidal anti-inflammatory drug tepoxalin inhibits interleukin-6 and alpha1-anti-chymotrypsin synthesis in astrocytes by preventing degradation of IkappaB-alpha. Neuropharmacology 38 (1999) 1325-1333
11. Han X.M., Holtzman D., McKeel Jr. D.W., Kelley J., and Morris J.C. Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis. J. Neurochem. 82 (2002) 809-818
12. Hehner S.P., Hofmann T.G., Droge W., and Schmitz M.L. The antiinflammatory sesquiterpene lactone parthenolide inhibits NF-kappa B by targeting the I kappa B kinase complex. J. Immunol. 163 (1999) 5617-5623
13. Herr I., Martin-Villalba A., Kurz E., Roncaioli P., Schenkel J., Cifone M.G., and Debatin K.M. FK506 prevents stroke-induced generation of ceramide and apoptosis signaling. Brain Res. 826 (1999) 210-219
14. 2 production from primary mouse astrocytes independent of nitric oxide formation. J. Neuroimmunol. 94 (1999) 134-143
15. Hou R.C., Huang H.M., Tzen J.T., and Jeng K.C. Protective effects of sesamin and sesamolin on hypoxic neuronal and PC12 cells. J. Neurosci. Res. 74 (2003) 123-133
16. Ide T., Ashakumary L., Takahashi Y., Kushiro M., Fukuda N., and Sugano M. Sesamin, a sesame lignan, decreases fatty acid synthesis in rat liver accompanying the down-regulation of sterol regulatory element binding protein-1. Biochim. Biophys. Acta 1534 (2001) 1-13
17. Ikeda S., Kagaya M., Kobayashi K., Tohyama T., Kiso Y., Higuchi N., and Yamashita K. Dietary sesame lignans decrease lipid peroxidation in rats fed docosahexaenoic acid. J. Nutr. Sci. Vitaminol. (Tokyo) 49 (2003) 270-276
18. Irizarry M.C., and Hyman B.T. Alzheimer disease therapeutics. J. Neuropathol. Exp. Neurol. 60 (2001) 923-928
19. Jain N.K., Patil C.S., Kulkarni S.K., and Singh A. Modulatory role of cyclooxygenase inhibitors in aging- and scopolamine or lipopolysaccharide-induced cognitive dysfunction in mice. Behav. Brain Res. 133 (2002) 369-376
20. Jengh A.K., and Singh I. Inflammatory mediator and beta-amyloid (25-35)-induced ceramide generation and iNOS expression are inhibited by vitamin E. Free Radic. Biol. Med. 37 (2004) 325-383
21. Jung K.M., Park K.S., Oh J.H., Jung S.Y., Yang K.H., Song Y.S., Son D.J., Park Y.H., Yun Y.P., Lee M.K., Oh K.W., and Hong J.T. Activation of p38 mitogen-activated protein kinase and activator protein-1 during the promotion of neurite extension of PC-12 cells by 15-deoxy-delta12,14-prostaglandin J2. Mol. Pharmacol. 63 (2003) 607-616
22. Kang M.H., Kawai Y., Naito M., and Osawa T. Dietary defatted sesame flour decreases susceptibility to oxidative stress in hypercholesterolemic rabbits. J. Nutr. 129 (1999) 1885-1890
23. Katsuzaki H., Kawakishi S., and Osawa T. Sesaminol glucosides in sesame seeds. Phytochemistry 35 (1994) 773-776
24. Kim S.R., Um M.Y., Ahn J.Y., Hong J.T., and Ha T.Y. The protective effects of sesaminol glycosides against cognitive deficits and oxidative stress induced by beta-amyloid protein in mice. Physiol. Funct. Dis. Risk Reduct. 3 (2003) 120
25. Kubota M., Narita K., Nakagomi T., Tamura A., Shimasaki H., Ueta N., and Yoshida S. Sphingomyelin changes in rat cerebral cortex during focal ischemia. Neurol. Res. 18 (1996) 337-341
26. Lee S.Y., Ha T.Y., Son D.J., Oh K.W., and Hong J.T. Effect of sesaminol glucosides on β-amyloid-induced PC12 cell death through antioxidant mechanisms. Neurosci. Res. 52 (2005) 330-341
27. Lee S.Y., Lee J.W., Lee H., Yoo H.S., Yun Y.P., Oh K.W., Ha T.Y., and Hong J.T. Inhibitory effect of green tea extract on beta-amyloid-induced PC12 cell death by inhibition of the activation of NF-kappaB and ERK/p38 MAP kinase pathway through antioxidant mechanisms. Brain Res. Mol. Brain Res. 140 (2005) 45-54
28. Lee S.Y., Son D.J., Ha T.Y., and Hong J.T. Protective effect of sesaminol glucosides on memory impairment and β-secretase activity in vivo. Yakhak Hoeji 49 (2005) 168-173
29. Leung C.H., Grill S.P., Lam W., Han Q.B., Sun H.D., and Cheng Y.C. Novel mechanism of inhibition of nuclear factor-kappa B DNA-binding activity by diterpenoids isolated from Isodon rubescens. Mol. Pharmacol. 68 (2005) 286-297
30. 2 in immortalized astrocytes (DITNC): response to genistein and pyrrolidine dithiocarbamate. J. Interferon Cytokine Res. 19 (1999) 121-127
31. Li Y., Liu L., Barger S.W., Mrak R.E., and Griffin W.S. Vitamin E suppression of microglial activation is neuroprotective. J. Neurosci. Res. 66 (2001) 163-170
32. Magnani M., Crinelli R., Bianchi M., and Antonelli A. The ubiquitin-dependent proteolytic system and other potential targets for the modulation of nuclear factor-kB (NF-kB). Curr. Drug Targets 1 (2000) 387-399
33. Matsuoka Y., Picciano M., Malester B., LaFrancois J., Zehr C., Daeschner J.M., Olschowka J.A., Fonseca M.I., O'Banion M.K., Tenner A.J., Lemere C.A., and Duff K. Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease. Am. J. Pathol. 158 (2001) 1345-1354
34. Mattson M.P. Pathways towards and away from Alzheimer's disease. Nature 430 (2004) 631-639
35. McGeer E.G., and McGeer P.L. Inflammatory processes in Alzheimer's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 27 (2003) 741-749
36. Obeid L.M., Linardic C.M., Karolak L.A., and Hannun Y.A. Programmed cell death induced by ceramide. Science 259 (1993) 1769-1771
37. Ohtani R., Tomimoto H., Kondo T., Wakita H., Akiguchi I., Shibasaki H., and Okazaki T. Upregulation of ceramide and its regulating mechanism in a rat model of chronic cerebral ischemia. Brain Res. 1023 (2004) 31-40
38. Ohtsuki T., Akiyama J., Shimoyama T., Yazaki S., Ui S., Hirose Y., and Mimura A. Increased production of antioxidative sesaminol glucosides from sesame oil cake through fermentation by Bacillus circulans strain YUS-2. Biosci. Biotechnol. Biochem. 67 (2003) 2304-2306
39. Okazaki T., Bielawska A., Bell R.M., and Hannun Y.A. Role of ceramide as a lipid mediator of 1 alpha, 25-dihydroxyvitamin D3-induced HL-60 cell differentiation. J. Biol. Chem. 265 (1990) 15823-15831
40. Park M.H., Song H.S., Kim K.H., Son D.J., Lee S.H., Yoon D.Y., Kim Y., Park I.Y., Song S., Hwang B.Y., Jung J.K., and Hong J.T. Cobrotoxin inhibits NF-kappa B activation and target gene expression through reaction with NF-kappa B signal molecules. Biochemistry 44 (2005) 8326-8336
41. Pawate S., Shen Q., Fan F., and Bhat N.R. Redox regulation of glial inflammatory response to lipopolysaccharide and interferongamma. J. Neurosci. Res. 77 (2004) 540-551
42. Puglielli L., Ellis B.C., Saunders A.J., and Kovacs D.M. Ceramide stabilizes beta-site amyloid precursor protein-cleaving enzyme 1 and promotes amyloid beta-peptide biogenesis. J. Biol. Chem. 278 (2003) 19777-19783
43. Rose J.W., Hill K.E., Watt H.E., and Carlson N.G. Inflammatory cell expression of cyclooxygenase-2 in the multiple sclerosis lesion. J. Neuroimmunol. 149 (2004) 40-49
44. Rossi A., Elia G., and Santoro M.G. Inhibition of nuclear factor kappa B by prostaglandin A1: an effect associated with heat shock transcription factor activation. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 746-750
45. Roussel R.R., and Barchowsky A. Arsenic inhibits NF-kappaB-mediated gene transcription by blocking IkappaB kinase activity and IkappaBalpha phosphorylation and degradation. Arch. Biochem. Biophys. 377 (2000) 204-212
46. Song S., Yang H., Uryu K., Lee E.B., Zhao L., Shineman D., Trojanowski J.Q., Lee V.M., and Pratico D. Modulation of nuclear factor-kappa B activity by indomethacin influences A beta levels but not A beta precursor protein metabolism in a model of Alzheimer's disease. Am. J. Pathol. 165 (2004) 2197-2206
47. Torreilles F., Salman-Tabcheh S., Guerin M., and Torreilles J. Neurodegenerative disorders: the role of peroxynitrite. Brain Res. Brain Res. Rev. 30 (1999) 153-163
48. Tuppo E.E., and Arias H.R. The role of inflammation in Alzheimer's disease. Int. J. Biochem. Cell Biol. 37 (2005) 289-305
49. Utsunomiya T., Shimada M., Rikimaru T., Hasegawa H., Yamashita Y., Hamatsu T., Yamasaki M., Kaku S., Yamada K., and Sugimachi K. Antioxidant and anti-inflammatory effects of a diet supplemented with sesamin on hepatic ischemia-reperfusion injury in rats. Hepatogastroenterology 50 (2003) 1609-1613
50. Verheij M., Bose R., Lin X.H., Yao B., Jarvis W.D., Grant S., Birrer M.J., Szabo E., Zon L.I., Kyriakis J.M., Haimovitz-Friedman A., Fuks Z., and Kolesnick R.N. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 380 (1996) 75-79
51. 2 phosphorylation and arachidonic acid release in primary murine astrocytes. J. Neurochem. 83 (2002) 259-270
52. Yamamoto Y., and Gaynor R.B. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J. Clin. Invest. 107 (2001) 135-142